期刊文献+

慢病毒介导siRNA干扰CEP55表达对卵巢癌细胞生物学行为的影响 被引量:1

Effects of lentiviral-mediated siRNA interference CEP55 expression on biological behavior of ovarian cancer cells
下载PDF
导出
摘要 本文通过慢病毒介导siRNA干扰卵巢癌SKOV3细胞中心体相关蛋白55(CEP55)表达,以观察其对细胞增殖、凋亡、侵袭和迁移等生物学行为的影响。实验分为CEP55组(转染CEP55 siRNA慢病毒)、阴性对照组(转染不含CEP55 siRNA的慢病毒)和空白对照组(不处理)。结果显示:CEP55 siRNA慢病毒转染效率为(89.4±4.7)%,CEP55组CEP55的mRNA和蛋白表达显著降低(P<0.05),第12、24、36、48、72 h时的OD(570)值显著降低(P<0.05),细胞凋亡率[(23.7±6.9)%]显著增加(P<0.05),穿膜细胞数目[(11.3±4.1)/个]明显减少(P<0.05),细胞迁移距离[(245.8±33.7)μm]明显减小(P<0.05)。提示慢病毒介导siRNA干扰CEP55表达可显著抑制卵巢癌SKOV3细胞增殖、促进其凋亡、降低其侵袭和迁移能力。 In this paper,the expression of CEP55 in SKOV3 cells was interfered by lentiviral-mediated siRNA,and its effect on proliferation,apoptosis,invasion and migration of cells was observed. The experiment was divided into CEP55 group,negative control group and blank control group. The CEP55 group and negative control group was transfected with lentiviral-mediated CEP55 siRNA and lentivirus vector without CEP55 siRNA,respectively. The blank control group did not do any treatment. The results of this study: the transfection efficiency of lentiviral-mediated CEP55 siRNA was( 89.4±4.7) %,the mRNA and protein expression of CEP55 in CEP55 group decreased significantly( P 〈 0. 05),the OD( 570)value in CEP55 group decreased significantly at 12,24,36,48 and 72 h,the apoptosis rate in CEP55 group [( 23. 7 ±6.9) %] increased significantly( P〈0.05),the number of crossed cells in CEP55 group( 11.3± 4.1) reduced significantly( P〈0.05),the migration distance in CEP55 group [( 245.8±33.7) μm]reduced obviously( P〈0.05). The results of this study suggested that lentiviral-mediated CEP55 siRNA can significantly inhibit the proliferation of SKOV3 cells,promote its apoptosis,and reduce its invasion and migration.
作者 陈春莹 程丽琴 付艳霞 CHEN Chunying;CHENG Liqin;FU Yanxia(Department of Gynaecology and obstetris,The Eighth Affiliated Hospital,Sunyat-sen University,Shenzhen 518000,Guangdong,China)
出处 《中南医学科学杂志》 CAS 2018年第4期358-361,364,共5页 Medical Science Journal of Central South China
基金 深圳市科技创新委员会科研项目资助(项目编号201774106)
关键词 慢病毒 中心体相关蛋白55 卵巢癌 生物学行为 lentivirus centrosomal protein of 55 ovarian cancer biological behavior
  • 相关文献

参考文献12

二级参考文献181

  • 1赵晓东,张毅.晚期卵巢上皮癌新辅助化疗[J].国外医学(肿瘤学分册),2005,32(4):310-313. 被引量:7
  • 2张慧敏.晚期卵巢癌新辅助化疗与常规辅助化疗结果比较[J].中国综合临床,2005,21(11):1016-1018. 被引量:5
  • 3叶雪(综述),牛昀,方志沂(审校).中心体异常、基因不稳定性与肿瘤[J].癌症,2005,24(10):1290-1292. 被引量:9
  • 4吴化平,颉彦华,赵其景,秦英.卵巢癌对顺铂耐药机制的研究进展[J].中国肿瘤临床,2006,33(21):1256-1259. 被引量:12
  • 5Lee S J, Kim BG, Lee J'W, et al. Preliminary results of neoedjuvant chemotherapy with paelitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery [J ]. Obstet Gynecol Res, 2006, 32 ( 1 ) : 90-106.
  • 6Pectasides D, Famakis D, Koumarianou A, et al. The role of neoadjuvant chemotherapy in the treatment of advanced ovarian cancerEJl. Ontology, 2005, 68 (1): 64-70.
  • 7连利娟 主编.林巧稚妇科肿瘤学[M].北京:人民卫生出版社,2001.356-372.
  • 8Moss EL, Hollingworth J, Reynolds TM. The role of CA125 in clinical practice.J Clin Pathol,2005,58:308-312.
  • 9Jacobs I. Discussion:ovarian cancer screening. Gynecol Oncol,2003,88:80-83.
  • 10Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 2002, 359(9306): 572-577.

共引文献120

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部